Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

283
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
283
Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Global Regulatory Systems01:28

Global Regulatory Systems

892
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
892
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

352
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
352
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

654
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
654
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

329
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulating the Use of Discontinuous Patterned Hydrogel to Improve Inter-Electrode Resistance on Electrode Arrays.

Artificial organs·2025
Same author

Sheffield Adaptive Patterned Electrical Stimulation (SHAPES) Therapy for Post Stroke Arm spasticity: study protocol for a 3-arm, a partially blinded, randomised controlled trial.

BMC neurology·2024
Same author

Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4).

Heart (British Cardiac Society)·2024
Same author

Sex differences in coronary microvascular resistance measured by a computational fluid dynamics model.

Frontiers in cardiovascular medicine·2023
Same author

Wearable technology and the cardiovascular system: the future of patient assessment.

The Lancet. Digital health·2023
Same author

Incorporating clinical parameters to improve the accuracy of angiography-derived computed fractional flow reserve<sup></sup>.

European heart journal. Digital health·2023
Same journal

News and Product Update.

Journal of medical engineering & technology·2026
Same journal

PMMA based ultra miniaturized implantable antenna for biotelemetry applications.

Journal of medical engineering & technology·2026
Same journal

Comparative machine learning for accurate EEG-based epileptic seizure state classification using sub-band analysis.

Journal of medical engineering & technology·2026
Same journal

Genetic algorithm-optimized machine learning approaches for EEG-based silent speech decoding.

Journal of medical engineering & technology·2026
Same journal

Power transition signatures of vibroarthrographic spectrograms for diagnosing knee joint pathologies.

Journal of medical engineering & technology·2026
Same journal

News and product update.

Journal of medical engineering & technology·2026
See all related articles

Related Experiment Video

Updated: Apr 2, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K

Standalone medical device software: The evolving regulatory framework.

Avril D McCarthy1,2,3, Patricia V Lawford4,5

  • 1a Medical Physics and Clinical Engineering .

Journal of Medical Engineering & Technology
|September 30, 2015
PubMed
Summary
This summary is machine-generated.

This paper clarifies regulatory requirements for standalone software, also known as software as a medical device (SaMD). It guides developers on classifying SaMD and finding essential regulatory resources.

Keywords:
Healthcare appsmedical deviceregulationsstandalone software

More Related Videos

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

678
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.2K

Related Experiment Videos

Last Updated: Apr 2, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

678
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.2K

Area of Science:

  • Medical Technology Regulation
  • Software as a Medical Device (SaMD) Classification
  • Regulatory Compliance for Health Software

Background:

  • The regulatory landscape for medical technology is complex, particularly for standalone software.
  • Standalone software, often termed 'software as a medical device' (SaMD), requires specific regulatory understanding.
  • Navigating SaMD regulations is crucial for market access and patient safety.

Purpose of the Study:

  • To introduce the regulatory framework governing SaMD.
  • To provide a clear understanding of how software with medical purposes is classified as a medical device.
  • To offer guidance and resources for SaMD developers.

Main Methods:

  • Review of the regulatory landscape for medical technology.
  • Analysis of six illustrative case studies involving SaMD.
  • Explanation of SaMD classification criteria.

Main Results:

  • SaMD can be classified as a medical device under specific regulatory conditions.
  • Case studies demonstrate practical applications of SaMD classification.
  • Key factors for classifying SaMD are detailed.

Conclusions:

  • Developers can effectively classify SaMD by understanding regulatory requirements.
  • The paper provides a roadmap for navigating SaMD regulations.
  • Access to regulatory support documents and contacts is facilitated for new developers.